CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma

被引：6
作者：
Cheng, Jian Y. [1 ,2 ]
Kananathan, Ratnavelu [1 ,2 ]
机构：
[1] Monash Univ, Cent Med Sch, Clayton, Vic, Australia
[2] NCI Hosp, Nilai, Negeri Sembilan, Malaysia
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2012年 / 8卷 / 12期
关键词：
lung; cimavax; epidermal growth factor (EGF); non small cell lung cancer (NSCLC); CANCER VACCINE; HUMAN VOLUNTEERS; CLINICAL-TRIAL; IMMUNOGENICITY; CHEMOTHERAPY; DIAGNOSIS; SURVIVAL; THERAPY; PROTEIN;
D O I：
10.4161/hv.21744
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
This case report documents the use of the CIMAvax Epidermal Growth Factor vaccine regimen in a 54 y old female with stage IIIb non-small cell lung carcinoma. Even after 48 mo since diagnosis her ECOG performance remains at zero. Further, this report documents a reaction to the vaccine of grade 3 severity not previously documented.
引用
收藏
页码：1799 / 1801
页数：3
相关论文
共 22 条
  • [1] [Anonymous], 2009, COMM TERM CRIT ADV E
  • [2] Allergy - 2. Anaphylaxis: diagnosis and management
    Brown, Simon G. A.
    Mullins, Raymond J.
    Gold, Michael S.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2006, 185 (05) : 283 - 289
  • [3] Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
    Chiang, Cheryl Lai-Lai
    Kandalaft, Lana E.
    Coukos, George
    [J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2011, 30 (2-3) : 150 - 182
  • [4] Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    D'Addario, G.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 39 - 40
  • [5] Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine
    Garcia, Beatriz
    Neninger, Elia
    de la Torre, Ana
    Leonard, Idrissa
    Martinez, Rocio
    Viada, Carmen
    Gonzalez, Gisela
    Mazorra, Zaima
    Lage, Agustin
    Crombet, Tania
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (03) : 840 - 846
  • [6] Cancer vaccines for hormone/growth factor immune deprivation:: A feasible approach for cancer treatment
    Gonzalez, G.
    Lage, A.
    [J]. CURRENT CANCER DRUG TARGETS, 2007, 7 (03) : 229 - 241
  • [7] Gonzalez G., 2002, Autoimmunity Reviews, V1, P89, DOI 10.1016/S1568-9972(01)00015-5
  • [8] Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy
    Gonzalez, G
    Crombet, T
    Torres, F
    Catala, M
    Alfonso, L
    Osorio, M
    Neninger, E
    Garcia, B
    Mulet, A
    Perez, R
    Lage, R
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (03) : 461 - 466
  • [9] A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
    Gonzalez, G
    Crombet, T
    Catala, M
    Mirabal, V
    Hernandez, JC
    Gonzalez, Y
    Marinello, P
    Guillen, G
    Lage, A
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (04) : 431 - 435
  • [10] Therapeutic vaccination with Epidermal Growth Factor (EGF) in advanced lung cancer -: Analysis of pooled data from three clinical trials
    Gonzalez, Gisela
    Crombet, Tania
    Neninger, Elia
    Viada, Carmen
    Lage, Agustin
    [J]. HUMAN VACCINES, 2007, 3 (01): : 8 - 13
123